ANG Lifesciences India Ltd — Results, 30-05-2025: Result

ANG Lifesciences India Limited has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025. The company reported a standalone net loss of ₹10.34 Cr and a consolidated net loss of ₹12.41 Cr for the year. Revenue declined compared to the previous year, with standalone revenue at ₹92.35 Cr and consolidated revenue at ₹94.86 Cr. Key expenses included cost of materials, employee benefits, finance costs, and depreciation. The auditors issued an unmodified opinion, confirming the fairness of the financial statements. The company continues its core operations in pharmaceutical manufacturing and packaging through its subsidiary.